Table 3.
Standardized mean differences (SMDs) and 95% CI on global symptom scores.
| B.coagulans | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| -1.65 (-2.37,-0.93) | C.butyricum | ||||||||
| -1.59 (-2.63,-0.55) | 0.06 (-1.07,1.19) | B.longum | |||||||
| -1.67 (-2.37,-0.97) | -0.02 (-0.84,0.81) | -0.08 (-1.20,1.04) | L.acidophilus | ||||||
| -1.70 (-2.47,-0.92) | -0.05 (-0.94,0.84) | -0.11 (-1.28,1.06) | -0.03 (-0.91,0.85) | L.salivarius | |||||
| -1.86 (-2.55,-1.18) | -0.21 (-1.03,0.60) | -0.27 (-1.38,0.84) | -0.20 (-0.99,0.60) | -0.17 (-1.03,0.70) | S.boulardii | ||||
| -1.94 (-2.42,-1.45) | -0.29 (-0.94,0.36) | -0.35 (-1.35,0.65) | -0.27 (-0.91,0.37) | -0.24 (-0.96,0.47) | -0.07 (-0.69,0.54) | B.infantis | |||
| -1.99 (-2.39,-1.59) | -0.40 (-1.36,0.57) | -0.05 (-0.32,0.22) | -0.34 (-0.93,0.26) | 0.28 (-0.45,1.01) | -0.29 (-0.95,0.37) | -0.74 (-1.47,-0.01) | PLA | ||
| -2.27 (-3.10,-1.43) | -0.62 (-1.56,0.32) | -0.68 (-1.89,0.53) | -0.60 (-1.53,0.33) | -0.57 (-1.56,0.41) | -0.41 (-1.32,0.51) | -0.33 (-1.11,0.45) | -0.21 (-0.68,0.25) | L.reuteri | |
| -2.20 (-2.82,-1.58) | -0.55 (-1.31,0.20) | -0.61 (-1.68,0.46) | -0.53 (-1.27,0.21) | -0.50 (-1.31,0.31) | -0.34 (-1.06,0.39) | -0.26 (-0.80,0.28) | 0.32 (-0.25,0.89) | 0.07 (-0.80,0.94) | L.plantarum |
Lower left triangle refers to the SMD from the network meta-analysis. (eg.,the SMD [95%CI] of global symptom scores between B.coagulans and placebo is -1.99[-2.39, -1.59]). The data in bold indicates that the effect size is statistically significant (P<0.05).